J. Sackner-Bernstein

Circulation · 2005–2006

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Whom J. Sackner-Bernstein trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Eric J. Topol

Who trusts J. Sackner-Bernstein overall

  1. M. Gheorghiade
  2. C. Yancy
  3. John A. Kellum
  4. N. Lameire

Papers from J. Sackner-Bernstein's perspective

Ordered by how strongly the researchers J. Sackner-Bernstein trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. (New England Journal of Medicine)
  2. Renal Insufficiency and Heart Failure: Prognostic and Therapeutic Implications From a Prospective Cohort Study (Circulation)
  3. Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart Failure (Circulation)
  4. Failing the public health--rofecoxib, Merck, and the FDA. (New England Journal of Medicine)
  5. Blood transfusion in elderly patients with acute myocardial infarction. (New England Journal of Medicine)
  6. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? (Critical Care Medicine)
  7. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. (New England Journal of Medicine)
  8. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. (New England Journal of Medicine)
  9. Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide (Circulation)
  10. Peripheral arterial disease detection, awareness, and treatment in primary care. (Journal of the American Medical Association (JAMA))

Their papers